ABL Bio Inc Capital Reinvestment Ratio
ABL Bio Inc capital reinvestment ratio. ABL Bio Inc (298380) has a Capital Reinvestment Ratio of 0.01x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩32.84 Billion) in capital expenditures (₩243.74 Million). See 298380 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ABL Bio Inc (2022–2022)
Capital reinvestment ratio of ABL Bio Inc from 2022 to 2022. This chart tracks ABL Bio Inc's Capital Reinvestment Ratio across 1 annual periods. See ABL Bio Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
ABL Bio Inc Capital Reinvestment Ratio by Year (2022–2022)
ABL Bio Inc capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see cash flow conversion of ABL Bio Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.03x | ₩72.13 Billion | ₩2.06 Billion | — |